GGrantIndex
← Search

Community Outreach and Engagement

$201,092P30FY2024CANIH

Albert Einstein College Of Medicine, Bronx NY

Investigators

Linked publications, trials & patents

Paper 39499645Paper 39392861Paper 39378878Paper 39332920Paper 39259591Paper 39207105Paper 39193906Paper 39127153Paper 39081315Paper 39028768Paper 39025270Paper 38902475Paper 38898085Paper 38896451Paper 38863869Paper 38778498Paper 38753503Paper 38717519Paper 38700353Paper 38699331Paper 38679747Paper 38657656Paper 38645169Paper 38643166Paper 38608634Paper 38597673Paper 38571760Paper 38565851Paper 38559037Paper 38477945Paper 38463959Paper 38458178Paper 38436133Paper 38405931Paper 38402617Paper 38400039Paper 38387080Paper 38352476Paper 38334805Trial NCT05016622Trial NCT04514484Trial NCT04401670Trial NCT03648983Trial NCT02774291Trial NCT02649569Trial NCT02578888Trial NCT02575872Trial NCT02527304Trial NCT02507076Trial NCT02382419Trial NCT02277561Trial NCT02112552Trial NCT02073968Trial NCT02038153Trial NCT02009436Trial NCT01958580Trial NCT01939210Trial NCT01899326Trial NCT01899261Trial NCT01897454Trial NCT01897441Trial NCT01857271Trial NCT01772420Trial NCT01697293Trial NCT01695941Trial NCT01605032Trial NCT01408160Trial NCT01367301Trial NCT01351909Trial NCT01319539Trial NCT01231906Trial NCT01145430Trial NCT01142401Trial NCT01061606Trial NCT01041027Trial NCT01001910Trial NCT00950365Trial NCT00470301Trial NCT00450944Trial NCT00437034Trial NCT00392353Trial NCT00324740Trial NCT00182767Trial NCT00179348Trial NCT00121251Trial NCT00096317Trial NCT00066638Trial NCT00057863Trial NCT00055692Trial NCT00030706Trial NCT00019474Trial NCT00004864Trial NCT00004863Trial NCT00003867Trial NCT00002461Patent 9671391Patent 7709613Patent 6821725Patent 6013468Patent 5876979

Abstract

Program Director/Principal Investigator (Last, First, Middle): Chu, Edward COMMUNITY OUTREACH AND ENGAGEMENT - PROJECT SUMMARY/ABSTRACT The overarching goal of the MECC Community Outreach and Engagement (COE) is to promote health equity and reduce disparities in cancer-related health outcomes in our Bronx catchment area (CA). More than 85% of patients who come to MECC for cancer care reside in this CA. The Bronx is a community of nearly 1.5 million residents, with 55% Hispanic/Latinx, 33% Black, 14% White, and 34% identifying with two or more races. Bronx residents are 35% foreign-born and 26% report difficulty with English. The Bronx is designated as a persistent poverty county with over 24% of residents living at or below the poverty level. The case mix of patients that come to MECC reflects this diversity. Cancer incidence in the Bronx is strongly associated with neighborhood poverty. As such, COE focuses on addressing social determinants of health in partnership with the community. Our specific aims are to: 1) Define, assess, and monitor cancer burden in the Bronx CA; 2) Develop, implement, and evaluate the impact of strategies to address the cancer burden; 3) Foster and facilitate catchment area- relevant research within all MECC Research Programs; 4) Enhance enrollment of underrepresented patients in clinical trials; and 5) Share lessons learned through dissemination to advance cancer health equity The MECC COE is led by Bruce Rapkin, PhD, Associate Director for COE. MECC’s COE efforts are built upon exceptionally strong relationships with community and health system partners. COE activities span the cancer continuum, from prevention and early detection to treatment to survivorship and supportive care. The COE team consists of project coordinators, data managers, and community outreach specialists, along with cancer patient advocates and pre-med interns. COE partners with community, clinic and public health sectors to leverage established programs and relationships. COE strategies are conceived and guided by a Community Advisory Board (CAB), COE liaisons from MECC Research Programs, and MECC Senior Leadership to ensure alignment of action, research, policy and practice. Our Learning Health Care Community logic model fosters on-going data- driven decision-making and problem-solving among these multiple stakeholders. Ongoing needs assessments provide direction and iterative feedback on metrics of success. Disseminating MECC research outcomes is intrinsic to the process. By addressing cancer equity in the broader context of social determinants through community partnerships, we have been able to arrive at solutions that are making a real difference in our CA. COE seeks to continue to expand and innovate as we work to become a national model for reducing cancer incidence and disparities in diverse populations. OMB No. 0925-0001/0002 (Rev. 03/2020 Approved Through 02/28/2023) Page

View original record on NIH RePORTER →